These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4036699)

  • 1. Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.
    Utermann G
    Adv Exp Med Biol; 1985; 183():173-88. PubMed ID: 4036699
    [No Abstract]   [Full Text] [Related]  

  • 2. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 6. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
    Hsia SH; Connelly PW; Hegele RA
    J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic variants of apo E: significance for triglyceride metabolism].
    Mann WA; Brewer HB; Greten H
    Z Gastroenterol Verh; 1991 Mar; 26():106. PubMed ID: 1714116
    [No Abstract]   [Full Text] [Related]  

  • 8. A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.
    Klasen EC; Talmud PJ; Havekes L; de Wit E; van der Kooij-Meijs E; Smit M; Hansson G; Humphries SE
    Hum Genet; 1987 Mar; 75(3):244-7. PubMed ID: 2881878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele.
    Rolleri M; Vivona N; Emmanuele G; Cefalù AB; Pisciotta L; Guido V; Noto D; Fiore B; Barbagallo CM; Notarbartolo A; Travali S; Bertolini S; Averna MR
    Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):93-9. PubMed ID: 12929622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.
    Richard P; de Zulueta MP; Beucler I; De Gennes JL; Cassaigne A; Iron A
    Atherosclerosis; 1995 Jan; 112(1):19-28. PubMed ID: 7772063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.
    Evans D; Seedorf U; Beil FU
    Clin Genet; 2005 Oct; 68(4):369-72. PubMed ID: 16143024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
    Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
    J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of apolipoprotein E variants by an oligonucleotide "melting" procedure.
    Funke H; Rust S; Assmann G
    Clin Chem; 1986 Jul; 32(7):1285-9. PubMed ID: 3719940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
    Lohse P; Mann WA; Stein EA; Brewer HB
    J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
    Couderc R; Bailleul S
    Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E in hyperlipidemia.
    Walden CC; Hegele RA
    Ann Intern Med; 1994 Jun; 120(12):1026-36. PubMed ID: 8185134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.